CS logo
small CS logo
Texas Epilepsy Group

Dallas, Texas, United States
Medical clinic in Dallas, Texas
12221 Merit Dr #350, Dallas, TX 75251

About Texas Epilepsy Group


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Texas Epilepsy Group


During the past decade, Texas Epilepsy Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Texas Epilepsy Group


According to Clinical.Site data, the most researched conditions in "Texas Epilepsy Group" are "Drug Resistant Partial Onset Seizure" (2 trials). Many other conditions were trialed in "Texas Epilepsy Group" in a lesser frequency.

Clinical Trials Intervention Types at Texas Epilepsy Group


Most popular intervention types in "Texas Epilepsy Group" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "ganaxolone" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Texas Epilepsy Group


The vast majority of trials in "Texas Epilepsy Group" are 2 trials for "All" genders.

Clinical Trials Status at Texas Epilepsy Group


Currently, there are NaN active trials in "Texas Epilepsy Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Texas Epilepsy Group, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Texas Epilepsy Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".